New stroke treatments and management strategies are available. Drugs like semaglutide, the active ingredient in a new wave of GLP-1 weight loss and diabetes drugs, also reduce the risk of stroke ...

A series of neutral trials on anticoagulation in embolic stroke of undetermined source (ESUS) has moved the needle scientifically but left physicians with questions about secondary prevention and ...

The following is a summary of “Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale,” published in the January 2024 issue of Cardiology by Zhang et al. In the ...

Atrial fibrillation in embolic stroke of undetermined source: role of advanced imaging of left atrial function. European Journal of Preventive Cardiology, 2023; DOI: 10.1093/eurjpc/zwad228 ...

About 20 to 40% of ischaemic stroke causes are cryptogenic. Embolic stroke of undetermined source (ESUS) is a subtype of cryptogenic stroke which is diagnosed based on specific criteria. Even though ...

The concept of embolic stroke of undetermined source (ESUS) was introduced by the cryptogenic stroke/ESUS international working group in 2014 (1). In patients with ESUS, the causal etiology might not ...

In a large cohort of young adult patients who experience an embolic stroke of undetermined source (ESUS), a relatively low rate of subsequent ischemic stroke has been reported compared with the rate ...

Evaluating rates of recurrent ischemic stroke among young adults with embolic stroke of undetermined source: the Young ESUS longitudinal cohort study. JAMA Neurol. Published online March 14, 2022 ...

Embolic Stroke of Undetermined Source (ESUS) is associated with fewer vascular risk factors, less disability, and a high recurrence rate. Objective: To compare risk factors, functional outcomes and ...

Patients with embolic stroke of undetermined source and left ventricular dysfunction may benefit from anticoagulation to prevent a further stroke, a new analysis of the NAVIGATE ESUS trial suggested.